338
Views
0
CrossRef citations to date
0
Altmetric
Genetic Disease

Value-based payment and financing for cell and gene therapies: challenges and potential solutions

&
Pages 678-681 | Received 25 Mar 2024, Accepted 19 Apr 2024, Published online: 27 Apr 2024
 

Transparency

Declaration of funding

No funding was received to produce this article.

Declaration of financial/other relationships

No financial/other relationships to disclose.

Author contributions

JXZ: conceptualization, manuscript development, and approval. LRS: manuscript development, and approval.

Acknowledgements

We thank three anonymous reviewers for their constructive comments.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.